Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 724 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Mr. Andrew Toy 2018 'den beri şirketle birlikte olan Clover Health Investments Corp 'in Chief Executive Officer 'ıdır.
CLOV hissesinin fiyat performansı nasıl?
CLOV 'in mevcut fiyatı $4.8 'dir, son işlem günde 1.79% disminuido etti.
Clover Health Investments Corp için ana iş temaları veya sektörler nelerdir?
Clover Health Investments Corp Health Care endüstrisine ait ve sektör Health Care 'dir
Clover Health Investments Corp 'in piyasa değerlemesi nedir?
Clover Health Investments Corp 'in mevcut piyasa değerlemesi $2.5B 'dir
Clover Health Investments Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 6 analist Clover Health Investments Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 3 tut, 0 sat ve 2 güçlü sat içermektedir